The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Alpha-Synuclein Imaging, 2011Consortium to Develop an Alpha-synuclein Imaging Agent
Objective/Rationale:
The ultimate goal of this project is develop a positron emission tomography (PET) radiotracer to image the distribution of alpha-synuclein in the brain. Alpha-synuclein imaging... -
Research Grant, 2011Testing Effects of Improved Levodopa Delivery with Dexterity and Gait Objective Measures
Objective/Rationale:
The objective of this project is to develop an extended-release capsule of levodopa/carbidopa (IPX066) that will result in constant blood levels of levodopa compared to current... -
Repositioning Drugs for PD, 2011Duloxetine Hydrochloride as a Novel Neuroprotective Treatment for Parkinson's Disease
Objective/Rationale:
In Parkinson’s disease (PD) dopaminergic neurons in the midbrain region substantia nigra pars compacta die. There is currently no treatment available that prevents this cell death... -
Repositioning Drugs for PD, 2011Evaluation of a Specific DAT Inhibitor in Pre-clinical Models of Parkinson's Disease
Objective/Rationale:
MLR-1017 is a psychostimulant drug used clinically for a variety of neuropsychiatric and other applications, but has never been tested in Parkinson’s disease (PD). Levodopa is a... -
Antibody Comparison, 2011Antibody Testing in Postmortem Human Brain
Objective/Rationale:
Mutations in the gene for LRRK2 are the most common genetic cause for Parkinson’s disease (PD) and therefore the LRRK2 protein appears to be important for normal brain function... -
Research Grant, 2011LRRK2 Antibody Comparison 2011
Objective/Rationale:
LRRK2 (Leucine-Rich Repeat Kinase 2) is a protein thought to be involved in regulating signaling pathways in cells. Mutations in the gene for LRRK2 are associated with some...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.